Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa

Authors

  • Addis Demissie

  • Addis Demissie

Keywords:

Abstract

I would like thank Prof. Yemane Berhane for his close

How to Cite

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa. (2013). Global Journal of Medical Research, 12(11), 1-8. https://medicalresearchjournal.org/index.php/GJMR/article/view/339

References

G Jackson, S Arver, I Banks, V Stecher (2010) Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. 64(4), 497-504.

Francesca Baratta, A, Paola Brusa (2012) Diffusion of counterfeit drugs in developing countries and stability of galenics stored for months under different conditions of temperature and relative humidity. 53, 173-184.

Amon, Jj (2008) Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs. 4(5), 1-10.

William Roberts (2008) Facts and Ideas from Anywhere. 21(1), 93-106.

Who (2010) Growing threat from counterfeit medicines. 88, 247-248.

May Cheng, Mm (2009) Is the Drugstore Safe? Counterfeit Diabetes Products on the Shelves. 3(6), 1516-1520.

N Paul, Aline Newton Fmfn, Dallas Planc¸on, Michael Mildenhall, Li Green, Eva Ziyong, S Christophel, Stephen Howells, Eric Mcintosh10, Paul Laurin, Nancy Blum, Christina Hampton, K, Leonard Nyadong, C Ray, Budiono Soong, Wang Santoso, John Zhiguang, K Newton (2008) A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia. 5(2).

Usman Hadi Pvdb, P Erni, Nun Kolopaking, Widjoseno Zairina, Gardjito, , Inge C Gyssens, ( Amrin) (2010) tSGARiIPaP. Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia. 10(203), 1-5.

Jap William G Meyer, Duane Hospenthal, Clinton Murray, Kurt Jerke, Anthony Hawksworth, David Metzgar, T, Douglas Walsh, Max Wu, Rosa Ergas, Uzo Chukwuma, Steven Tobias, John Klena, I, Maha Talaat, Ryan Maves, Michael Ellis, Glenn Wortmann, David Blazes, L Lindler (2011) Antimicrobial resistance surveillance in the AFHSC-GEIS network. 11, 8.

Robert Cockburn, Paul Newton, E Agyarko, Dora Akunyili, Nicholas White (2005) The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. 2(4), e100.

Lucy Reynolds, Martin Mckee (2010) Organised crime and the efforts to combat it: a concern for public health. 6(1), 21.

Sivong Sengaloundeth, Michael Green, Facundo Fernández, Ot Manolin, Khamlieng Phommavong, Vongsavanh Insixiengmay, Christina Hampton, Leonard Nyadong, Dallas Mildenhall, Dana Hostetler, Lamphet Khounsaknalath, Latsamy Vongsack, Samlane Phompida, Viengxay Vanisaveth, Lamphone Syhakhang, Paul Newton (2009) A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. 8(1), 1-10.

G Aa Amin (2007) ANTIMALARIAL DRUG QUALITY IN AFRICA. 32(5), 429-440.

J Christopher, C Whitty, Evelyn Ansah, Toby Leslie, Sarah Staedke (2008) Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. 7, 7.

Maria Cristina Gaudiano, Adm, Emilia Cocchieri, Eleonora Antoniella, Paola Bertocchi, Stefano Alimonti, Luisa Valvo (2007) Medicines informal market in Congo, Burundi and Angola:counterfeit and substandard antimalarials. 6(22), 1-9.

Jimmy Volmink, L (2005) Antimalarial treatment with artemisinin combination therapy in Africa :Desirable, achievable, but not easy. 331(1), 1-2.

Jean-Robert Ioset, H (2009) Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations. 4(9), 1-8.

N Paul, R Newton, Facundo Fernandez, Michael Green, Manuela Sunjio, Carinne Bruneton, Souly Phanouvong, P Christopher, J Whitty, Ambrose Talisuna, Stephane Proux, Eva Maria Christophel, Grace Malenga, P, Kalifa Bojang, Harparkash Kaur, Kevin Palmer, P Nicholas, Brian Day, François Greenwood, Njw Nosten (2006) Manslaughter by Fake Artesunate in Asia-Will Africa Be Next?. 3(6), 752-0754.

Obinna Onwujekwe, Harparkash Kaur, Nkem Dike, Elvis Shu, Benjamin Uzochukwu, Kara Hanson, Viola Okoye, Paul Okonkwo (2009) Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. 8(1), 1-9.

Douglas Macpherson, William Bdg, Shukal Baine, Paul Bala, Paul Gubbins, Ms-N Holtom (2009) Population Mobility, Globalization,and Antimicrobial Drug Resistance. 15, 1727-1732.

Amy Sapkota, Mec, Rachel Rosenberg Goldstein, Nancy Atkinson, Shauna Sweet Unknown Title.

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa

Published

2013-01-08

How to Cite

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa. (2013). Global Journal of Medical Research, 12(11), 1-8. https://medicalresearchjournal.org/index.php/GJMR/article/view/339